Boothe Investment Group »

SPDR S&P Biotech shares owned by Boothe Investment Group

Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by Boothe Investment Group from 13F filings

Historical chart of Boothe Investment Group investment in SPDR S&P Biotech

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Biotech held by Boothe Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Biotech by Boothe Investment Group

Quarter filed Position value Share count Share price at filing
2024-09-30 $6.3M 64k 98.80
2024-06-30 $6.0M 65k 93.04
2018-09-30 $2.8M 29k 95.87
2018-06-30 $2.7M 28k 95.20

More positions owned by Boothe Investment Group

Victory Portfolios Ii Victoryshares Sm (SFLO)
RBB Us Treasy 2 Yr (UTWO)
Doubleline Etf Trust Opportunistic Bd (DBND)
J P Morgan Exchange Traded F Ultra Sht Muncpl (JMST)
Alibaba Group Hldg Sponsored Ads (BABA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Servicenow (NOW)
Kinross Gold Corp (KGC)
Citigroup Com New (C)
Bank of America Corporation (BAC)
Crowdstrike Hldgs Cl A (CRWD)
Meta Platforms Cl A (META)
Pfizer (PFE)
Advanced Micro Devices (AMD)
Spdr Ser Tr S&p Biotech (XBI)

View all positions for Boothe Investment Group

Top funds holding SPDR S&P Biotech

Goldman Sachs Group
Jpmorgan Chase & Co
Healthcare Of Ontario Pension Plan Trust Fund
Bank of America Corporation
Citigroup
Jane Street
Citadel Advisors
Morgan Stanley
Susquehanna International
NWI Management
Bnp Paribas Arbitrage, Snc
Twin Tree Management
Parallax Volatility Advisers
Wells Fargo & Company
Logos Global Management

View all funds holding SPDR S&P Biotech